Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world-Reference-Cited by-同舟云学术

Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world

Published:2012-03 Issue:3 Volume:155 Page:424-429
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Ruff Christian T.,Giugliano Robert P.,Antman Elliott M.,Murphy Sabina A.,Lotan Chaim,Heuer Herbertus,Merkely Bela,Baracioli Luciano,Schersten Fredrik,Seabro-Gomes Ricardo,Braunwald Eugene,Wiviott Stephen D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. The World Health Report 2000 health systems: improving performance;World Health Organization,2000

2. Outcomes of interventions for IHD. OECD Study of cross-national differences in the treatment, costs and outcomes of ischaemic heart disease;Moise,2003

3. Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis;Chang;J Epidemiol Community Health,2005

4. International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2;Gupta;Eur Heart J,2003

5. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II;Giugliano;Eur Heart J,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. REDUCE-IT USA;Circulation;2020-02-04

2. Performance of acute coronary syndrome approaches in Brazil: a report from the BRACE (Brazilian Registry in Acute Coronary SyndromEs);European Heart Journal - Quality of Care and Clinical Outcomes;2019-08-10

3. Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia - 2019;Arquivos Brasileiros de Cardiologia;2019

4. Variation in Patient Profiles and Outcomes in US and Non-US Subgroups of the Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION) PHOENIX Trial;Circulation: Cardiovascular Interventions;2016-06

5. Prasugrel (Efient (R)) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis;HEALTH TECHNOL ASSES;2015